Recoverin antibody-associated late-onset ataxia without retinopathy

Rebecca Herzog; Norbert Brüggemann; Andreas Sprenger; Thomas F. Münte

doi:10.1136/bcr-2020-237479

Recoverin antibody-associated late-onset ataxia without retinopathy

Rebecca Herzog^*, Norbert Brüggemann, Andreas Sprenger, Thomas F. Münte

^*Corresponding author for this work

Clinic of Neurology

Abstract

Acquired cerebellar ataxia is a rare, in many cases immune-modulated and paraneoplastic illness. Acute and slowly progredient processes are possible. An early treatment is important for a good clinical outcome. Here we present the case of female patient in her 60s with an antirecoverin associated cerebellitis without retinopathia and neoplasia. After an immunosuppressive therapy with steroids and rituximab the symptoms improved, and the progression could be stopped.

Original language	English
Article number	e237479
Journal	BMJ Case Reports
Volume	13
Issue number	12
DOIs	https://doi.org/10.1136/bcr-2020-237479
Publication status	Published - 17.12.2020

Research Areas and Centers

Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/bcr-2020-237479

Cite this

@article{1527b50e83a74479932093265945b2df,

title = "Recoverin antibody-associated late-onset ataxia without retinopathy",

abstract = "Acquired cerebellar ataxia is a rare, in many cases immune-modulated and paraneoplastic illness. Acute and slowly progredient processes are possible. An early treatment is important for a good clinical outcome. Here we present the case of female patient in her 60s with an antirecoverin associated cerebellitis without retinopathia and neoplasia. After an immunosuppressive therapy with steroids and rituximab the symptoms improved, and the progression could be stopped. ",

author = "Rebecca Herzog and Norbert Br{\"u}ggemann and Andreas Sprenger and M{\"u}nte, {Thomas F.}",

note = "Publisher Copyright: {\textcopyright} BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2020",

month = dec,

day = "17",

doi = "10.1136/bcr-2020-237479",

language = "English",

volume = "13",

journal = "BMJ Case Reports",

issn = "1757-790X",

number = "12",

}

TY - JOUR

T1 - Recoverin antibody-associated late-onset ataxia without retinopathy

AU - Herzog, Rebecca

AU - Brüggemann, Norbert

AU - Sprenger, Andreas

AU - Münte, Thomas F.

PY - 2020/12/17

Y1 - 2020/12/17

N2 - Acquired cerebellar ataxia is a rare, in many cases immune-modulated and paraneoplastic illness. Acute and slowly progredient processes are possible. An early treatment is important for a good clinical outcome. Here we present the case of female patient in her 60s with an antirecoverin associated cerebellitis without retinopathia and neoplasia. After an immunosuppressive therapy with steroids and rituximab the symptoms improved, and the progression could be stopped.

AB - Acquired cerebellar ataxia is a rare, in many cases immune-modulated and paraneoplastic illness. Acute and slowly progredient processes are possible. An early treatment is important for a good clinical outcome. Here we present the case of female patient in her 60s with an antirecoverin associated cerebellitis without retinopathia and neoplasia. After an immunosuppressive therapy with steroids and rituximab the symptoms improved, and the progression could be stopped.

UR - http://www.scopus.com/inward/record.url?scp=85098675702&partnerID=8YFLogxK

U2 - 10.1136/bcr-2020-237479

DO - 10.1136/bcr-2020-237479

M3 - Journal articles

C2 - 33334756

AN - SCOPUS:85098675702

SN - 1757-790X

VL - 13

JO - BMJ Case Reports

JF - BMJ Case Reports

IS - 12

M1 - e237479

ER -

Recoverin antibody-associated late-onset ataxia without retinopathy

Abstract

Research Areas and Centers

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this